Skip to main content

Greenberg Traurig’s Nancy Taylor Participates in RFK Compass Live Session

WASHINGTON, D.C. – Sept. 11, 2020 – Nancy E. Taylor, shareholder and co-chair of the Health Care & FDA Practice at global law firm Greenberg Traurig, LLP, participated in the Robert F. Kennedy (RFK) Human Rights Compass Live session, “Healthcare Investing in a Pandemic:  Delivering Care While Seeking Opportunities.” The firm also sponsored the program.

RFK Compass Live virtual gatherings bring together key decision-makers in the investment community to help inform, challenge, and inspire asset owners and allocators to think differently about the effects their investments have on society. Similar to the RFK Compass Investor Conferences, RFK Compass Live engages its select network of asset owners and allocators as well as investment consultants and academics.

Taylor moderated the webinar, which included panelists Charles Boorady, Managing Director of Health Catalyst Capital; Scott Pittman, SVP and CIO of Mount Sinai Medical Center; and John DiGiovanni, Investment Partner at Arsenal Capital. The discussion focused on the innovative new business models arising from the pandemic, how reshaping the existing healthcare infrastructure can increase efficiency, and investment opportunities in the sector.

Taylor has broad experience working with providers, plans, employers, private equity firms, and FDA regulated companies. She advises clients on health care transactions, health and FDA regulatory policy and compliance, and responding to Congressional and Administration investigations and audits. Prior to joining Greenberg Traurig, Taylor served 10 years as Health Policy Director for a Senate Committee and worked on a number of significant health and FDA laws. She also served as CEO of a start-up medical device company, where she obtained eight product clearances, including securing reimbursement coverage for each product.

About Greenberg Traurig’s Health Care & FDA Practice: Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing healthcare marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2200 attorneys in 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: Twitter: @GT_Law.